GXI DE000A0LD6E6

Report

Delayed Xetra - 05/14 11:35:27 am
91.6	EUR		+2.23%

05/03

GERRESHEIMER : with innovative SensAIR platform for first drug delivery device for biologics

04/28

ECODESIGN : Lightweight, stable and resource-saving - this is how design and production benefit from digital simulation of the glass molding process

04/20

GERRESHEIMER AG : Buy rating from Berenberg

Calendar

Upcoming events on GERRESHEIMER AG

05/18/21
05/25/21
06/01/21
06/09/21

Past events on GERRESHEIMER AG

05/13/21
04/08/21 \| 09:00am
04/08/21 \| 02:49am
03/18/21

Upcoming sector events for GERRESHEIMER AG

05/17/21		GETINGE AB : CPhI Discover conference
05/18/21		AMBU A/S : Berenberg US Conference
05/18/21		COLOPLAST A/S : Berenberg US Conference
05/18/21 \| 07:00am		SONOVA HOLDING AG : FY 2021 Earnings Call

More events

Past sector events for GERRESHEIMER AG

05/14/21 \| 11:00am		DIASORIN S.P.A. : Q1 2021 Earnings Call
05/14/21		ZIMMER BIOMET HOLDINGS, INC. : Annual General Meeting
05/14/21		ASAHI INTECC CO., LTD. : Q3 2021 Earnings Release
05/14/21		DIASORIN S.P.A. : Q1 2021 Earnings Release

Annual publications

Annual results		2016	2017	2018	2019	2020	2021 (e)
Sales M €	Released Forecast Spread	1 376 1 428 -3,7%	1 348 1 354 -0,41%	1 368 1 373 -0,35%	1 392 1 422 -2,1%	1 419 1 422 -0,23%	1 474
Operating income (EBITDA) M €	Released Forecast Spread	308 316 -2,5%	311 302 2,8%	299 291 2,6%	400 411 -2,8%	310 307 0,91%	321
Operating profit (EBIT) M €	Released Forecast Spread	180 204 -11%	181 185 -2,1%	139 154 -9,5%	124 261 -53%	156 158 -1,1%	182
Pre-Tax Profit (EBT) M €	Released Forecast Spread	147 155 -5,1%	145 145 0,34%	107 114 -6,3%	98,2 235 -58%	135 143 -5,4%	154
Net income M €	Released Forecast Spread	168 107 58%	101 99,9 1,0%	129 114 13%	80,8 185 -56%	88,6 98,6 -10%	113
EPS €	Released Forecast Spread	3,87 3,48 11%	3,21 3,19 0,50%	4,11 3,70 11%	2,57 6,37 -60%	2,82 3,14 -10%	3,58
Announcement Date		02/15/2017	02/22/2018	02/14/2019	02/19/2020	02/18/2021

Quarterly publications

Previous period

Next period

Quarterly results		2016 S1	2017 S1	2018 S1	2018 Q4	2019 Q1	2019 Q2	2019 S1	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 S1	2020 Q3	2020 Q4	2021 Q1	2021 Q2 (e)	2021 Q3 (e)	2021 Q4 (e)	2021 S1 (e)
Sales M €	Released Forecast Spread	713 724 -1,5%	642 670 -4,1%	623 622 0,15%	391 394 -0,80%	309 308 0,12%	357 354 0,76%	665 658 1,1%	359 361 -0,55%	369 395 -6,6%	304 309 -1,5%	363 363 -0,12%	667 674 -1,0%	349 354 -1,3%	403 406 -0,79%	303 302 0,17%	375	373	414
Operating income (EBITDA) M €	Released Forecast Spread	151 146 2,9%	136 147 -7,6%	124 126 -1,7%	101 95,1 6,2%	53,6 54,8 -2,2%	100 69,1 45%	246 169 46%	72,2 71,8 0,53%	81,5 95,4 -15%	51,0 52,9 -3,6%	84,0 77,7 8,2%		75,0 75,0 0,05%	99,9 98,9 0,98%	54,2 51,1 6,1%	86,0	78,4	104	137
Operating profit (EBIT) M €	Released Forecast Spread	86,3 81,5 5,8%	72,2 83,2 -13%	54,4 61,9 -12%	47,4 56,1 -15%	109 102 6,5%	61,4 31,0 98%	170 138 24%	33,8 33,2 1,8%	-80,4 55,3 -245%	11,9 14,3 -17%	46,5 38,1 22%	58,3 51,1 14%	43,8 40,5 8,3%	54,3 68,0 -20%	19,2 16,0 20%	52,9	45,2	67,9	71,9
Pre-Tax Profit (EBT) M €	Released Forecast Spread			35,6 43,0 -17%					26,8 26,1 2,8%	-85,8 46,5 -284%	6,96 6,00 16%	40,8 29,8 37%		38,3 38,7 -1,00%		14,5 12,0 21%
Net income M €	Released Forecast Spread	48,7 42,1 16%	37,5 44,4 -16%	67,4 72,5 -7,0%	43,1 35,3 22%	99,3 96,5 2,9%	46,6 16,3 185%	145 113 28%	18,5 18,4 0,51%	-83,2 35,0 -338%	4,14 5,10 -19%	29,0 22,3 30%	33,1 27,2 22%	25,4 24,2 4,9%	30,0 33,0 -9,0%	9,20 7,60 21%	34,8	29,1	45,9	44,6
EPS	Released Forecast Spread	1,45 1,34 8,4%	1,19 1,42 -16%	2,15 2,31 -6,9%	1,37 1,16 18%	3,15 3,19 -1,1%	1,48 0,55 169%	4,63 3,61 28%	0,59 0,61 -2,9%	-2,65 1,10 -342%	0,13 0,12 8,3%	0,92 0,70 32%	1,05 0,87 21%	0,81 0,81 0,62%	0,96 1,39 -31%	0,29 0,29 1,8%	1,11	0,93	1,46	1,42
Announcement Date		07/07/2016	07/13/2017	07/11/2018	02/14/2019	04/11/2019	07/11/2019	07/11/2019	10/10/2019	02/19/2020	04/09/2020	07/14/2020	07/14/2020	10/13/2020	02/18/2021	04/08/2021

Stock Pick

GERRESHEIMER AG
Manufacturer of syringes and vaccine doses

More Recommendations

Net sales (Year) - Rate of surprise

EPS (Year) - Rate of surprise

Net sales (Quarter) - Rate of surprise

EPS (Quarter) - Rate of surprise